Cargando…
Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221910/ https://www.ncbi.nlm.nih.gov/pubmed/34217512 http://dx.doi.org/10.1016/j.neurol.2021.05.002 |
| _version_ | 1783711410763595776 |
|---|---|
| author | Aubignat, M. |
| author_facet | Aubignat, M. |
| author_sort | Aubignat, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8221910 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82219102021-06-25 Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic Aubignat, M. Rev Neurol (Paris) Editorial Elsevier Masson SAS. 2021-10 2021-06-24 /pmc/articles/PMC8221910/ /pubmed/34217512 http://dx.doi.org/10.1016/j.neurol.2021.05.002 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Aubignat, M. Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title | Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title_full | Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title_fullStr | Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title_full_unstemmed | Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title_short | Clozapine-related immunodeficiency: Implications for Parkinson's disease psychosis in the context of the COVID-19 pandemic |
| title_sort | clozapine-related immunodeficiency: implications for parkinson's disease psychosis in the context of the covid-19 pandemic |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221910/ https://www.ncbi.nlm.nih.gov/pubmed/34217512 http://dx.doi.org/10.1016/j.neurol.2021.05.002 |
| work_keys_str_mv | AT aubignatm clozapinerelatedimmunodeficiencyimplicationsforparkinsonsdiseasepsychosisinthecontextofthecovid19pandemic |